Diagnosis of Neonatal Late-Onset Infection in Very Preterm Infant: Inter-Observer Agreement and International Classifications.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 01 2021
Historique:
received: 26 11 2020
revised: 14 01 2021
accepted: 14 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 24 4 2021
Statut: epublish

Résumé

The definition of late-onset bacterial sepsis (LOS) in very preterm infants is not unified. The objective was to assess the concordance of LOS diagnosis between experts in neonatal infection and international classifications and to evaluate the potential impact on heart rate variability and rate of "bronchopulmonary dysplasia or death". A retrospective (2017-2020) multicenter study including hospitalized infants born before 31 weeks of gestation with intention to treat at least 5-days with antibiotics was performed. LOS was classified as "certain or probable" or "doubtful" independently by five experts and according to four international classifications with concordance assessed by Fleiss's kappa test. LOS was suspected at seven days (IQR: 5-11) of life in 48 infants. Following expert classification, 36 of them (75%) were considered as "certain or probable" (kappa = 0.41). Following international classification, this number varied from 13 to 46 (kappa = -0.08). Using the expert classification, "bronchopulmonary dysplasia or death" occurred less frequently in the doubtful group (25% vs. 78%, The definition of LOS is not consensual with a low international and moderate inter-observer agreement. This affects the evaluation of associated organ dysfunction and prognosis.

Sections du résumé

BACKGROUND
The definition of late-onset bacterial sepsis (LOS) in very preterm infants is not unified. The objective was to assess the concordance of LOS diagnosis between experts in neonatal infection and international classifications and to evaluate the potential impact on heart rate variability and rate of "bronchopulmonary dysplasia or death".
METHODS
A retrospective (2017-2020) multicenter study including hospitalized infants born before 31 weeks of gestation with intention to treat at least 5-days with antibiotics was performed. LOS was classified as "certain or probable" or "doubtful" independently by five experts and according to four international classifications with concordance assessed by Fleiss's kappa test.
RESULTS
LOS was suspected at seven days (IQR: 5-11) of life in 48 infants. Following expert classification, 36 of them (75%) were considered as "certain or probable" (kappa = 0.41). Following international classification, this number varied from 13 to 46 (kappa = -0.08). Using the expert classification, "bronchopulmonary dysplasia or death" occurred less frequently in the doubtful group (25% vs. 78%,
CONCLUSION
The definition of LOS is not consensual with a low international and moderate inter-observer agreement. This affects the evaluation of associated organ dysfunction and prognosis.

Identifiants

pubmed: 33498557
pii: ijerph18030882
doi: 10.3390/ijerph18030882
pmc: PMC7908350
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2012 Jun 9;379(9832):2151-61
pubmed: 22579125
Pediatr Res. 2020 Jul;88(1):85-90
pubmed: 31394566
Pediatrics. 2002 Aug;110(2 Pt 1):285-91
pubmed: 12165580
Early Hum Dev. 2018 Feb;117:83-89
pubmed: 29351876
IEEE J Biomed Health Inform. 2020 Mar;24(3):681-692
pubmed: 31295130
Pediatrics. 2009 Jan;123(1):58-66
pubmed: 19117861
PLoS One. 2017 Jun 22;12(6):e0180134
pubmed: 28640920
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Pediatr. 2015 May;166(5):1193-9
pubmed: 25919728
J Pediatr. 2011 Nov;159(5):720-5
pubmed: 21784435
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Front Pediatr. 2018 Nov 13;6:346
pubmed: 30542642
Curr Opin Pediatr. 2016 Apr;28(2):135-40
pubmed: 26766602
J Pediatr. 2019 May;208:176-182.e6
pubmed: 30853200
Pediatr Infect Dis J. 2017 Dec;36(12):e293-e297
pubmed: 28719503
Neonatology. 2009;96(2):109-14
pubmed: 19279394
Front Physiol. 2020 Jun 17;11:585
pubmed: 32625107
Front Pediatr. 2018 Oct 09;6:280
pubmed: 30356758
IEEE J Biomed Health Inform. 2020 Sep 03;PP:
pubmed: 32881699
BMC Pediatr. 2018 May 23;18(1):172
pubmed: 29792168
Infect Dis (Lond). 2018 Oct;50(10):764-770
pubmed: 29969049
Pediatr Res. 2020 Jul;88(1):14-26
pubmed: 32126571
Clin Perinatol. 2010 Sep;37(3):581-98
pubmed: 20813272
Virulence. 2014 Jan 1;5(1):4-11
pubmed: 24335434
Arch Dis Child Fetal Neonatal Ed. 2001 Jul;85(1):F36-41
pubmed: 11420320
PLoS One. 2019 Oct 29;14(10):e0223785
pubmed: 31661497
J Pediatr. 2014 Apr;164(4):775-80
pubmed: 24412138
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Children (Basel). 2019 Dec 01;6(12):
pubmed: 31805647
Am J Perinatol. 2015 Jun;32(7):675-82
pubmed: 25486288
Lancet. 2017 Oct 14;390(10104):1770-1780
pubmed: 28434651
Neonatology. 2014;105(2):98-107
pubmed: 24296586
Crit Care. 2018 Nov 21;22(1):316
pubmed: 30463590
JAMA Pediatr. 2015 Dec;169(12):1162-72
pubmed: 26457641
Pediatr Res. 2018 Jan;83(1-1):13-15
pubmed: 29019470
Indian Pediatr. 2014 Aug;51(8):647-50
pubmed: 25128999
Eur J Pediatr. 2013 Apr;172(4):501-8
pubmed: 23271492
J Matern Fetal Neonatal Med. 2015;28(18):2244-9
pubmed: 25367556
Pediatr Res. 2013 Nov;74(5):570-5
pubmed: 23942558
JAMA. 2004 Nov 17;292(19):2357-65
pubmed: 15547163
Crit Care Med. 1992 Jun;20(6):864-74
pubmed: 1597042
Clin J Pain. 2009 Sep;25(7):607-16
pubmed: 19692803
Mol Med. 2015 Jun 02;21:496-504
pubmed: 26052715
Cochrane Database Syst Rev. 2019 Jan 14;1:CD012126
pubmed: 30640979
Eur J Pediatr. 2018 Jan;177(1):33-38
pubmed: 29063210
Sci Rep. 2019 Oct 29;9(1):15448
pubmed: 31664055

Auteurs

Gaelle Bury (G)

Department of Neonatology, CHU Rennes, Rennes University, Inserm-CIC 1414, F-35033 Rennes, France.

Stéphanie Leroux (S)

Department of Neonatology, CHU Rennes, Rennes University, Inserm-CIC 1414, F-35033 Rennes, France.

Cristhyne Leon Borrego (C)

LTSI-UMR_S Inserm 1099, University of Rennes, F-35000 Rennes, France.

Christèle Gras Leguen (C)

Department of Neonatology, University Hospital of Nantes, F-44000 Nantes, France.

Delphine Mitanchez (D)

Department of Neonatology, University Hospital of Tours, F-37044 Tours, France.

Geraldine Gascoin (G)

Department of Neonatology, University Hospital of Angers, F-49100 Angers, France.

Aurore Thollot (A)

Department of Neonatology, University Hospital of Poitiers, F-86021 Poitiers, France.

Jean Michel Roué (JM)

Department of Neonatology, University Hospital of Brest, F-29200 Brest, France.

Guy Carrault (G)

LTSI-UMR_S Inserm 1099, University of Rennes, F-35000 Rennes, France.

Patrick Pladys (P)

Department of Neonatology, CHU Rennes, Rennes University, Inserm-CIC 1414, F-35033 Rennes, France.
LTSI-UMR_S Inserm 1099, University of Rennes, F-35000 Rennes, France.

Alain Beuchée (A)

Department of Neonatology, CHU Rennes, Rennes University, Inserm-CIC 1414, F-35033 Rennes, France.
LTSI-UMR_S Inserm 1099, University of Rennes, F-35000 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH